Zentalis Pharmaceuticals Llc
Biotechnology
Healthcare
ZNTL
71.11 M shares
NASDAQ US
traded
24 Jun 2025
listed
no
open
1.30
52 week high
4.47
high
1.39
52 week low
1.34
low
1.29
growth
-65.99 %
previous Close
1.38
P/E ratio
market cap
229 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-40.16 M
54.51 %
eps
0.00 %
54.84 %
eps surprise
35.69 %
net profit margin
-4015800000.00 %
0.00 %
operating incoming
-51.43 M
21.05 %
net change in cash
4.29 M
770.31 %
cash on hand
41.32 M
11.75 %
cost of revenue
0.00 %
top top